These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32683301)

  • 61. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
    Zhang Z; Li Z; Liu Z; Zhang X; Yu N; Xu Z
    J Cell Biochem; 2020 Jul; 121(7):3606-3615. PubMed ID: 31961022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Function of NEK2 in clear cell renal cell carcinoma and its effect on the tumor microenvironment.
    Tang P; Zheng G; Xu C; Yu N; Du J; Hu L; Zhou Z; Zheng Y
    Medicine (Baltimore); 2024 May; 103(20):e37939. PubMed ID: 38758909
    [TBL] [Abstract][Full Text] [Related]  

  • 64. L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma.
    Song J; Jin C; Chen E; Dong X; Zhu L
    Biomed Res Int; 2021; 2021():6648182. PubMed ID: 33829062
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
    Şenbabaoğlu Y; Gejman RS; Winer AG; Liu M; Van Allen EM; de Velasco G; Miao D; Ostrovnaya I; Drill E; Luna A; Weinhold N; Lee W; Manley BJ; Khalil DN; Kaffenberger SD; Chen Y; Danilova L; Voss MH; Coleman JA; Russo P; Reuter VE; Chan TA; Cheng EH; Scheinberg DA; Li MO; Choueiri TK; Hsieh JJ; Sander C; Hakimi AA
    Genome Biol; 2016 Nov; 17(1):231. PubMed ID: 27855702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
    Qiu X; Gu Y; Ni Y; Li Q
    Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
    Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
    Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.
    Yu Y; Chen G; Jiang C; Guo T; Tang H; Yuan Z; Wang Y; Tan X; Chen J; Zhang E; Wang X
    J Gene Med; 2024 Jan; 26(1):e3594. PubMed ID: 37699648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
    Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
    Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
    Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
    FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
    Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J
    Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
    Wang Z; Wang K; Gao X; Liu Z; Xing Z
    PLoS One; 2022; 17(6):e0269595. PubMed ID: 35675366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
    Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
    Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma.
    Yang W; Li L; Zhang K; Ma K; Gong Y; Zhou J; Gong K
    Epigenomics; 2021 Jan; 13(1):31-45. PubMed ID: 33203244
    [No Abstract]   [Full Text] [Related]  

  • 77. Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration.
    Liu JP; Jiang YF; Liu JW; Tian CJ; Lin YZ; Yang YZ; Zhang ZK; Fang YL; Huang B; Lin H
    Cancer Med; 2024 Aug; 13(15):e70072. PubMed ID: 39108036
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
    Braun DA; Street K; Burke KP; Cookmeyer DL; Denize T; Pedersen CB; Gohil SH; Schindler N; Pomerance L; Hirsch L; Bakouny Z; Hou Y; Forman J; Huang T; Li S; Cui A; Keskin DB; Steinharter J; Bouchard G; Sun M; Pimenta EM; Xu W; Mahoney KM; McGregor BA; Hirsch MS; Chang SL; Livak KJ; McDermott DF; Shukla SA; Olsen LR; Signoretti S; Sharpe AH; Irizarry RA; Choueiri TK; Wu CJ
    Cancer Cell; 2021 May; 39(5):632-648.e8. PubMed ID: 33711273
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma.
    Yang H; Zhang H; Zhang L; Tusuphan P; Zheng J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175461
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.